An actuarial life table details the likelihood of an individual dying within the next year. Discover how it predicts mortality risks and helsp determine pricing.

Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...

Objective To evaluate sex differences in perioperative characteristics, in-hospital outcomes and long-term survival following ...

Aura Minerals Inc. (Nasdaq: AUGO) (B3: AURA33) ("Aura" or the "Company") is pleased to announce that it has signed the agreement of ...

Record quarterly and full year net revenues of $247.1 million and $883.4 million, up 29.6% and 43.8% year-over-year, respectivelyTotal Rare Disease quarterly and full year net revenue of $131.3 millio ...

American Tungsten Corp. (CSE: TUNG) (OTCQB: TUNGF) (FSE: RK90) (“American Tungsten” or the “Company”) is pleased to report ...

Objective Unplanned hospital readmissions within 30 days of discharge measure the quality of healthcare. This study aims to ...

Objectives The mental health impacts of COVID-19 on frontline healthcare workers have been reported globally; however, there is limited evidence from low-income countries such as Ethiopia. We reviewed ...

Discover how to conduct break-even analysis in Excel using Goal Seek and spreadsheet examples, helping you assess ...